can semaglutide affect liver Wegovy Treated Severe Disease in Large Clinical Trial Semaglutide as a GLP-1 Agonist:

Only 28.8% of participants exceeded 1 mg/week

AS FEATURED IN Unlock your results Adjust your height and weight below to see your personalized results Estimated weight loss: -17lbs Your BMI is 29.2, which is higher than 38% of the population

Youre nauseated: Nausea is the most common side effect of semaglutide medications

After activating GLP-1R, Semaglutide promotes insulin secretion, inhibits gastric emptying and appetite, and at the same time enhances autophagy, inhibits oxidative stress and apoptosis

Clinical trials are now needed to confirm these protective effects in patients and explore whether GLP-1 receptor agonists can slow, or even halt, the progression of this vision-robbing condition.